Results 201 to 210 of about 1,343,630 (268)

Exploring the evidence of direct threats to cetaceans from maritime vessels: A systematic map. [PDF]

PLoS One
Ferrari V, Hague E, Sciberras M, Alexander KA, O'Hara PD, McWhinnie L.   +5 more
europepmc   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

FEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi, João C. Encarnação, Valeria Napolitano, Grzegorz Dubin, Grzegorz Popowicz, Karl Andersson, U. Helena Danielson   +6 more
wiley   +1 more source

Method of Removal of Aquatic Pond Weed Variably Impacts Presence of Potentially Toxic Cyanobacteria. [PDF]

MicroPubl Biol
Princiotta SD, Ostergaard E, Carroll E.
europepmc   +1 more source

Investigating transcription factor dynamics in health and disease using FRAP

FEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj, Carolina Vazquez Garzon, Jose Joaquin Velasco, Janine N. Post   +3 more
wiley   +1 more source

Public participation, institutional trust, and distributive justice in wind and solar projects. [PDF]

Environ Manage
Miguel T, Robaina M, Botelho A, Lima F, Ramalho E, Madaleno M.   +5 more
europepmc   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

FEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille   +3 more
wiley   +1 more source

The quality-of-life impacts and economic burden of X-linked retinitis pigmentosa caused by variants in RPGR. [PDF]

Eye (Lond)
Schofield D, Kraindler J, Shrestha RN, Tan O, West S, Hart N, Wall L, Tan L, Hewett D, Villaret L, Ma A, Grigg JR, Jamieson RV.   +12 more
europepmc   +1 more source

The therapeutic opportunities and pitfalls of using iron ion chelators to treat neurodegenerative diseases

FEBS Letters, EarlyView.
Although too much iron in the brain promotes neurodegeneration, iron ion chelators have had mixed effects in clinical trials. This review explains why; some chelators do not render the iron redox‐inactive (e.g., L1) whereas others do (e.g., desferrioxamine).
Barry Halliwell
wiley   +1 more source

Socio-ecological impacts of the 2025 Los Angeles urban fires on communities, neighborhoods, and homes. [PDF]

Nat Commun
Norlen CA, Sharma S, Escobedo FJ.
europepmc   +1 more source